The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Affiliation
Heidelberg University Hospital Center
Country
Germany
1. Current Status, Position
- Deputy Head of Pharmacy Department since 2009. Dr Schoening is in charge of Oncology Pharmacy Unit together with central preparation unit of cytotoxic drugs
- Pharmaceutical management of clinical studies phase I-III in accordance to GCP and GMP
- Quality management representative
- Lecturer of clinical pharmacy in the School of Pharmacy
- Lecturer of pharmacology in the School of Nursing
2. Education
- 2000 (2nd of June): Licensure as Pharmacist
- 2001-2009: PhD (Dr. sc. hum.), University of Heidelberg
– Thesis: “Antimicrobial susceptibility of clinical Group-B-streptococci isolates and molecular typing of resistant strains from two different german regions”
– examination 2009 - Since 2004: Specialist in Hospital Pharmacy (“Klinische Pharmazie”, PharmD)
- Member of the Clinical Pharmacy Board of ADKA (German Association of Hospital Pharmacists)
- Spokesman of the Oncology Board of ADKA
- Vice President German Association of Oncology Pharmacy (DGOP)
3. Research Area
Dr Schoening is specialized in Oncology Pharmacy. In particular cytotoxic drugs and renal insufficiency, computerized physician order entry systems and standardization of supportive measures in oncology